The ambulatory infusion center market involves administration of medications through infusion therapy. Infusion therapy delivers medications, nutrients, blood products and other fluids directly into a patient’s bloodstream, bypassing the gastrointestinal tract. This mode of therapy is often used to treat complex and chronic conditions such as cancer, autoimmune disorders, infections and other diseases. The infusion centers enable safe and effective administration of medications to patients without requiring an overnight hospital stay.
Market key trends:
One of the major trends driving the growth of the ambulatory infusion center market is increasing use of infusion therapy. Infusion therapy is gaining prominence owing to advantages such as targeted drug delivery, rapid onset of action and improved efficacy. It allows administration of antibiotics, chemotherapy drugs, immunoglobulins, pain medications, nutrients and other IV fluids directly into the bloodstream. The infusion therapy market has witnessed significant growth in recent years owing to rising cases of chronic diseases like cancer and diabetes that require IV medication. Growth in the aging population who are more prone to chronic illnesses is also fueling the demand for ambulatory infusion centers across major countries.
The global Ambulatory Infusion Center Market Size is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Threat of new entrants: Low capital requirements and established brand loyalty makes it difficult for new players to enter.
Bargaining power of buyers: Buyers have high bargaining power due to presence of many players and availability of substitutes.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of substitute medication suppliers and services.
Threat of new substitutes: Substitutes like home healthcare services pose threat to the market.
Competitive rivalry: High due to presence of many regional and international players.
Strength: Large patient pool with chronic diseases, growing geriatric population and availability of reimbursements.
Weakness: High setup and operational costs, shortage of trained staff, and stringent regulations.
Opportunity: Increasing healthcare expenditure, rising preference for outpatient services and growth in medical tourism.
Threats: Risk of medication errors and infections.
The global Ambulatory Infusion Center Market is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasing prevalence of chronic diseases.
Regionally, North America dominates the global market and is expected to grow at 7.1% CAGR during the forecast period. This is attributed to presence of advanced healthcare infrastructure and favorable reimbursement policies in the US and Canada.
Key players operating in the Ambulatory Infusion Center market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare. The key players are focused on mergers and acquisitions to strengthen their geographical presence.